Finance

Lists
Why is DWTX up 8.39%?
Dive Deeper
DWTX:NASDAQ
Dogwood Therapeutics Inc
$1.55
+8.39%
(+0.12) 1D
Oct 2, 11:24:00 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DWTX...
Open
$1.45
High
$1.56
Low
$1.45
Mkt. cap
52.69M
Avg. vol.
74.35K
Volume
8.26K
52-wk high
$7.20
52-wk low
$1.28
EPS
-$8.95
Beta
1.93
Shares outstanding
33.99M
No. of employees
8
Open
$1.45
High
$1.56
Low
$1.45
Mkt. cap
52.69M
Avg. vol.
74.35K
Volume
8.26K
52-wk high
$7.20
52-wk low
$1.28
EPS
-$8.95
Beta
1.93
Shares outstanding
33.99M
No. of employees
8
News stories
From web sources and news partners
About Dogwood Therapeutics Inc
CEO-
Employees8
Founded2012
HeadquartersAlpharetta, Georgia, United States
SectorBiotechnology
Websitedwtx.com
Analyst ratings
Based on 2 analysts giving stock ratings to DWTX in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for DWTX in the last 3 months.
Highest
Current $1.55
$15.00 (+867.74%)
Average
$13.50 (+770.97%)
Lowest
$12.00 (+674.19%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sean Lee CFA
H.C. Wainwright
Buy
Reiterated
$12.00
+674.2%
10/01/2026
Jason McCarthy
Maxim Group
Buy
Reiterated
$15.00
+867.7%
09/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
14.52M
2.34M
2.67M
3.25M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.29M
1.47M
2.39M
1.61M
Operating expense
15.81M
3.81M
5.06M
4.86M
Total operating expenses
15.81M
3.81M
5.06M
4.86M
Operating income
-15.81M
-3.81M
-5.06M
-4.86M
Other non operating income
-
-
-
-
EBT including unusual items
-15.75M
-3.75M
-4.99M
-14.01M
EBT excluding unusual items
-15.75M
-3.75M
-4.99M
-4.82M
Income tax expense
-1.44K
31.84K
1.19K
-2.48M
Effective tax rate
0.01%
-0.85%
-0.02%
17.71%
Other operating expenses
-
-
-
-
Net income
-15.74M
-3.78M
-4.99M
-11.53M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
80.58K
52.07K
77.35K
66.35K
Interest expense
-
-
-
-
Net interest expenses
80.58K
52.07K
77.35K
66.35K
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.81M
-3.81M
-5.06M
-4.85M
Gain or loss from assets sale
-
2.73K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps